Greater Manchester is one of the first regions ready to tackle problematic polypharmacy in primary care. Greater Manchester Academic Health Science Network are working in partnership with Haelo to explore how improvement can be achieved for this complex issue.
Do you want to reduce the risk of adverse drug interactions for your patients?
Do you want to reduce the cost of medications waste?
Do you want to improve health outcomes and quality of life for your patients?
Then you need to be part of our innovative and exciting 90 day rapid improvement cycle, focusing on the reduction of problematic polypharmacy in primary care. Using a new national polypharmacy database, generated from electronic prescribing, we will help understand your numbers of patients in key high risk medication categories that could benefit from review.